Hansa Biopharma AB (OSTO:HNSA)
kr 42.46 0.62 (1.48%) Market Cap: 2.78 Bil Enterprise Value: 3.18 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 73/100

Q2 2023 Hansa Biopharma AB Earnings Call Transcript

Jul 20, 2023 / 12:00PM GMT
Release Date Price: kr45.06 (+1.49%)
Operator

Good afternoon, and welcome to the Hansa Biopharma Quarter 2 2023 Conference Call. My name is Carla, and I will be the operator for today's call. (Operator Instructions)

I would now like to pass the conference over to our host, Søren Tulstrup to begin. Please go ahead when you're ready.

SÃ;ren Tulstrup;publ;President;CEO
Hansa Biopharma AB

¸ - ()-&

Thank you, operator. Good morning, good afternoon, and welcome to the Hansa Biopharma conference call to review second quarter 2023 results. I'm Søren Tulstrup, CEO of Hansa Biopharma. Joining me today is our Chief Commercial Officer and newest President, Matt Shaulis, and our CFO, Donato Spota; our Head of Investor Relations, Klaus Sindahl, is also with us.

Today, we'll discuss the highlights and progress we made during the second quarter of 2023 and review our near-term milestones. The presentation should take roughly 20 minutes, after which there will be an opportunity to ask questions during the Q&A session.

Please

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot